Attached files
| file | filename |
|---|---|
| EX-5.1 - EX-5.1 - ReShape Lifesciences Inc. | d249485dex51.htm |
| EX-4.3 - EX-4.3 - ReShape Lifesciences Inc. | d249485dex43.htm |
| EX-4.2 - EX-4.2 - ReShape Lifesciences Inc. | d249485dex42.htm |
| EX-4.1 - EX-4.1 - ReShape Lifesciences Inc. | d249485dex41.htm |
| EX-1.1 - EX-1.1 - ReShape Lifesciences Inc. | d249485dex11.htm |
| S-1/A - AMENDMENT NO. 3 TO FORM S-1 - ReShape Lifesciences Inc. | d249485ds1a.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Amendment No. 2 to Registration Statement No. 333-213704 on Form S-1 of our report dated March 28, 2016, relating to the consolidated financial statements of EnteroMedics Inc. and subsidiary, appearing in the Annual Report on Form 10-K of EnteroMedics Inc. for the year ended December 31, 2015, and to the reference to us under the heading “Experts” in the Prospectus, which is part of such Registration Statement.
| /s/ Deloitte & Touche LLP |
| Minneapolis, Minnesota |
| January 6, 2017 |